These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38951408)

  • 1. External Evaluation of Population Pharmacokinetic Models of Piperacillin in Preterm and Term Patients from Neonatal Intensive Care.
    Boer-Pérez FS; Lima-Rogel V; Mejía-Elizondo AR; Medellín-Garibay SE; Rodríguez-Báez AS; Rodríguez-Pinal CJ; Milán-Segovia RDC; Romano-Moreno S
    Eur J Drug Metab Pharmacokinet; 2024 Sep; 49(5):595-607. PubMed ID: 38951408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
    Greppmair S; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Marsot A; El-Haffaf I; Zoller M; Saller T; Zander J; Schatz LM; Scharf C; Briegel J; Minichmayr IK; Wicha SG; Liebchen U
    Intensive Care Med; 2023 Aug; 49(8):966-976. PubMed ID: 37439872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.
    Li Z; Chen Y; Li Q; Cao D; Shi W; Cao Y; Wu D; Zhu Y; Wang Y; Chen C
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1223-33. PubMed ID: 23354809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
    Matcha S; Dillibatcha J; Raju AP; Chaudhari BB; Moorkoth S; Lewis LE; Mallayasamy S
    Paediatr Drugs; 2023 May; 25(3):365-375. PubMed ID: 36943583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
    Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
    Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
    Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
    Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set.
    Hughes JH; Tong DMH; Faldasz JD; Frymoyer A; Keizer RJ
    Clin Pharmacokinet; 2023 Jan; 62(1):67-76. PubMed ID: 36404388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.
    Felton TW; Roberts JA; Lodise TP; Van Guilder M; Boselli E; Neely MN; Hope WW
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4094-102. PubMed ID: 24798288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of piperacillin using scavenged samples from preterm infants.
    Cohen-Wolkowiez M; Benjamin DK; Ross A; James LP; Sullivan JE; Walsh MC; Zadell A; Newman N; White NR; Kashuba AD; Ouellet D
    Ther Drug Monit; 2012 Jun; 34(3):312-9. PubMed ID: 22569355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.
    Chen Y; Lu J; Dong M; Wu D; Zhu Y; Li Q; Chen C; Li Z
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1479-1488. PubMed ID: 27644691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses.
    El-Haffaf I; Caissy JA; Marsot A
    Clin Pharmacokinet; 2021 Jul; 60(7):855-875. PubMed ID: 33876381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients.
    El-Haffaf I; Guilhaumou R; Velly L; Marsot A
    Clin Pharmacokinet; 2022 Jun; 61(6):895-906. PubMed ID: 35344155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates.
    Stockmann C; Hersh AL; Roberts JK; Bhongsatiern J; Korgenski EK; Spigarelli MG; Sherwin CM; Frymoyer A
    Infect Dis Ther; 2015 Jun; 4(2):187-98. PubMed ID: 25998107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients.
    Sturm AW; Allen N; Rafferty KD; Fish DN; Toschlog E; Newell M; Waibel B
    Pharmacotherapy; 2014 Jan; 34(1):28-35. PubMed ID: 23864417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants.
    Engbers AGJ; Flint RB; Voeller S; Reiss I; Liem KD; Alffenaar JC; Tibboel D; Simons S; Knibbe CAJ; Brüggemann RJ
    Arch Dis Child; 2022 Apr; 107(4):400-406. PubMed ID: 35074829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.
    Cohen-Wolkowiez M; Watt KM; Zhou C; Bloom BT; Poindexter B; Castro L; Gao J; Capparelli EV; Benjamin DK; Smith PB
    Antimicrob Agents Chemother; 2014 May; 58(5):2856-65. PubMed ID: 24614369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.
    van den Broek MP; Huitema AD; van Hasselt JG; Groenendaal F; Toet MC; Egberts TC; de Vries LS; Rademaker CM
    Clin Pharmacokinet; 2011 Jul; 50(7):461-9. PubMed ID: 21651313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients.
    Verhaeghe J; Dhaese SAM; De Corte T; Vander Mijnsbrugge D; Aardema H; Zijlstra JG; Verstraete AG; Stove V; Colin P; Ongenae F; De Waele JJ; Van Hoecke S
    BMC Med Inform Decis Mak; 2022 Aug; 22(1):224. PubMed ID: 36008808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.